ATXIOTCPharmaceutical PreparationsFiscal year ends December 31
AVENUE THERAPEUTICS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$0.43+0.00 (0.00%)
Close on Oct 16, 2026
- Market cap
- $1.42M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Who owns Avenue Therapeutics's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Fortress Biotech, Inc. | 439,955 | 13.40% | 13D (active) amendment | Jan 2, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Neil Herskowitz | Director | 97 | 0.00% | Dec 3, 2024 |
| Jay D. Kranzler | Director | 559 | 0.02% | Nov 7, 2024 |
| Fortress Biotech, Inc. | 10% owner | 689,733 | 20.93% | Jan 6, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Fortress Biotech, Inc. 10% owner | Jan 2, 2026 | Award | +111,209 | – | – | 439,733 |
| Fortress Biotech, Inc. 10% owner | Mar 31, 2025 | Award | +33,724 | – | – | 328,524 |
| Neil Herskowitz Director | Dec 2, 2024 | Sale | −23 | $2.00 | $46 | 97 |
| Jay D. Kranzler Director | Nov 5, 2024 | Sale | −61 | $2.24 | $137 | 559 |
| Jay D. Kranzler Director | Sep 30, 2024 | Buy | +497 | $2.50 | $1.24K | 620 |
| Jay D. Kranzler Director | Sep 27, 2024 | Buy | +3 | $2.40 | $7 | 123 |
| David Jin Interim PFO and COO | Sep 23, 2024 | Award | +65,000 | – | – | 65,000 |
| Alexandra MacLean Chief Executive Officer, Director | Sep 23, 2024 | Award | +170,000 | – | – | 170,000 |
| Fortress Biotech, Inc. 10% owner | Apr 16, 2024 | Award | +413,507 | – | – | 3,547,393 |
| Fortress Biotech, Inc. 10% owner | Jan 2, 2024 | Award | +2,101,496 | – | – | 3,133,886 |
| Robert L. Davidow 10% owner | Dec 11, 2023 | Sale | −264,000 | $0.14 | $36.96K | 681,000 |
| Robert L. Davidow 10% owner | Dec 11, 2023 | Sale | −20,000 | $0.14 | $2.80K | 80,000 |
| Robert L. Davidow 10% owner | Dec 11, 2023 | Sale | −18,000 | $0.15 | $2.70K | 22,000 |
| Robert L. Davidow 10% owner | Dec 11, 2023 | Sale | −61,000 | $0.14 | $8.54K | 74,000 |
| Robert L. Davidow 10% owner | Dec 11, 2023 | Sale | −126,000 | $0.14 | $17.64K | 215,800 |
| Robert L. Davidow 10% owner | Dec 11, 2023 | Sale | −128,000 | $0.14 | $17.92K | 147,000 |
| Fortress Biotech, Inc. 10% owner | Sep 8, 2023 | Buy | +418,410 | $0.72 | $301.26K | 1,032,390 |
| Lindsay A. Rosenwald Md Director | Sep 8, 2023 | Buy | +348,675 | $0.72 | $251.05K | 354,318 |
| Fortress Biotech, Inc. 10% owner | Mar 31, 2023 | Award | +52,419 | – | – | 613,980 |
| Fortress Biotech, Inc. 10% owner | Jan 3, 2023 | Award | +231,316 | – | – | 561,561 |
| Fortress Biotech, Inc. 10% owner | Dec 31, 2022 | Award | +90,909 | – | – | 330,245 |
| InvaGen Pharmaceuticals, Inc. 10% owner | Oct 11, 2022 | Sale | −388,888 | $7.71 | $3.00M | 0 |
| Jay D. Kranzler Director | Dec 17, 2021 | Award | +49,020 | – | – | 113,683 |
| Jay D. Kranzler Director | Dec 17, 2021 | Award | +20,000 | – | – | 133,683 |
| Curtis Gale Oltmans Director | Dec 17, 2021 | Award | +49,020 | – | – | 49,020 |
| Neil Herskowitz Director | Dec 17, 2021 | Award | +20,000 | – | – | 183,744 |
| Neil Herskowitz Director | Dec 17, 2021 | Award | +49,020 | – | – | 163,744 |
| Joseph Walter Vazzano Chief Financial Officer | Dec 17, 2021 | Award | +100,505 | – | – | 165,757 |
| Lucy Lu President, CEO, Director | Dec 17, 2021 | Award | +411,616 | – | – | 748,949 |
| Joseph Walter Vazzano Chief Financial Officer | Sep 15, 2021 | Sale | −7,160 | $1.62 | $11.60K | 65,252 |
| Neil Herskowitz Director | May 6, 2021 | Buy | +2,500 | $3.99 | $9.98K | 134,724 |
| Joseph Walter Vazzano Chief Financial Officer | Aug 20, 2020 | Sale | −3,840 | $12.13 | $46.58K | 57,412 |
| Jay D. Kranzler Director | Jun 16, 2020 | Award | +10,000 | – | – | 84,663 |
| Neil Herskowitz Director | Jun 16, 2020 | Award | +10,000 | – | – | 132,224 |
| Joseph Walter Vazzano Chief Financial Officer | Mar 10, 2020 | Buy | +1,889 | $7.94 | $15.00K | 61,252 |
| Joseph Walter Vazzano Chief Financial Officer | Mar 9, 2020 | Buy | +1,400 | $7.99 | $11.19K | 59,263 |
| Joseph Walter Vazzano Chief Financial Officer | Mar 9, 2020 | Buy | +100 | $7.97 | $797 | 59,363 |
| Neil Herskowitz Director | Feb 27, 2020 | Buy | +2,400 | $8.20 | $19.68K | 122,224 |
| Neil Herskowitz Director | Feb 26, 2020 | Buy | +161 | $8.73 | $1.41K | 119,824 |
| Joseph Walter Vazzano Chief Financial Officer | Feb 25, 2020 | Buy | +1,200 | $9.09 | $10.91K | 57,863 |
| Neil Herskowitz Director | Feb 25, 2020 | Buy | +10,000 | $9.31 | $93.10K | 119,663 |
| Elizabeth Garrett Ingram Director | Sep 12, 2019 | Buy | +16,000 | $6.27 | $100.32K | 16,000 |
| Neil Herskowitz Director | Aug 27, 2019 | Award | +10,000 | – | – | 109,663 |
| Jay D. Kranzler Director | Aug 27, 2019 | Award | +10,000 | – | – | 74,663 |
| Joseph Walter Vazzano Chief Financial Officer | Aug 9, 2019 | Sale | −2,375 | $5.56 | $13.20K | 56,663 |
| Joseph Walter Vazzano Chief Financial Officer | Aug 8, 2019 | Sale | −2,313 | $5.62 | $13.00K | 59,038 |
| Neil Herskowitz Director | Jun 18, 2019 | Buy | +2,000 | $5.83 | $11.66K | 99,663 |
| Neil Herskowitz Director | Jun 17, 2019 | Buy | +3,000 | $5.88 | $17.64K | 97,663 |
| Neil Herskowitz Director | Apr 15, 2019 | Buy | +1,000 | $4.52 | $4.52K | 94,663 |
| Neil Herskowitz Director | Mar 29, 2019 | Buy | +1,400 | $5.11 | $7.15K | 93,663 |
| Neil Herskowitz Director | Mar 28, 2019 | Buy | +600 | $5.11 | $3.07K | 92,263 |
| Neil Herskowitz Director | Feb 25, 2019 | Buy | +5,000 | $5.46 | $27.30K | 91,663 |
| Neil Herskowitz Director | Feb 5, 2019 | Buy | +1,850 | $5.77 | $10.67K | 86,663 |
| Neil Herskowitz Director | Feb 4, 2019 | Buy | +7,000 | $5.91 | $41.37K | 84,813 |
| Neil Herskowitz Director | Jan 30, 2019 | Buy | +650 | $5.91 | $3.84K | 77,813 |
| Neil Herskowitz Director | Jan 29, 2019 | Buy | +8,553 | $5.91 | $50.55K | 77,163 |
| Neil Herskowitz Director | Jan 28, 2019 | Buy | +1,447 | $5.84 | $8.45K | 68,610 |
| Jeffrey Paley Director | Dec 10, 2018 | Buy | +5,000 | $4.76 | $23.80K | 79,663 |
| Jeffrey Paley Director | Dec 3, 2018 | Buy | +10,000 | $5.48 | $54.80K | 74,663 |
| Jeffrey Paley Director | Aug 7, 2018 | Gift | +14,663 | – | – | 64,663 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.